It was registered a decrease on OLYMPUS CORPORATION ORDINARY SHARES JAP (OTCMKTS:OCPNF)’s shares shorted with 7.54%. FINRA announced in March OCPNF’s total 202,400 shares shorted. Previously was reported down change of 7.54% from 218,900 shares. 506 days will cost OCPNF with 400 average volume to recover its former position.

$43.6 was the last price.It’s since March 10, 2018 and is 0.00% down. The stock underperformed the S&P 500 by 4.37%.

Olympus Corporation manufactures and sells precision machineries and instruments worldwide.The firm is worth $15.73 billion. It operates through four divisions: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business.75.43 is the P/E ratio. The firm offers endoscopic video imaging systems, gastrointestinal/colono/duodeno/broncho endoscopes, endoscopic ultrasound systems, ultrasound endoscopes/probes, ultrasound centers, capsule endoscopy systems, medical information systems, therapeutic peripherals, and ancillary products, as well as cleaning, disinfecting, and sterilization systems; endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, anesthesiology, and otolaryngology; therapeutic and surgical equipment, and peripherals; and endotherapy products.

Another two news for Olympus Corporation (OTCMKTS:OCPNF) were recently published by: Seekingalpha.com on July 25, 2016 with title “Olympus’ New M&A Strategy: Identifying Potential Targets – Seeking Alpha”. The other Seekingalpha.com‘s article was titled “Olympus: A Financial ‘House Of Cards’ With 20% Downside – Seeking Alpha” and published on January 27, 2016.